Let’s Transform Transplant Medicine. Together.

Achieving more through our shared commitment to transplant medicine

See our pipeline

Learn more about who we are at Veloxis

Expand video transcript

Veloxis, an Asahi Kasei company

At Veloxis, our focus is developing new therapies and programs to help transplant healthcare providers and the patients they treat. Now part of a global network, Veloxis is reaching further and growing faster, enabling us to continue being who we are as a company: Agile, Efficient, Responsive. Veloxis is following through on our promise to transform the future of transplant. Let’s transform transplant medicine. Together.

We know what transplant means to patients, and we’re leading innovation to improve their experience

For patients, transplant is a life-changing procedure. But changes come with challenges. At Veloxis, our mission is to see and respond to the challenges along the transplant journey. Our focus is developing new therapies and programs to help transplant healthcare providers and the patients they treat.

As part of a global network, Veloxis is reaching further and growing faster

As an Asahi Kasei company, we are able to expand our presence as a partner in care and innovation in medicine. The support and structured framework we have as part of Asahi Kasei enables us to be who we are as a company: agile, efficient, and responsive.

Meet our leadership
Briefcase
Careers At Veloxis

“Veloxis’s Human Resources Department prides itself in providing an exceptional workplace environment for all employees. We strive to maintain a dynamic and innovative workplace that embraces diversity and encourages professional development. Our employees are our top priority!”

Rita Mannella, Executive Director, Human Resources

Keep up with our headlines to see what we’ve been working on

Press Release
PRESS RELEASE
2024-05-30

Veloxis Pharmaceuticals Selected to Present at the 2024 American Transplant Congress in Philadelphia

Veloxis Pharmaceuticals, Inc. (Veloxis), a fully integrated specialty pharmaceutical company, is pleased to announce the presentation of VEL-101 research at the 2024 American Transplant Congress (ATC).

Read More
Press Release
PRESS RELEASE
2024-03-28

Veloxis Pharmaceuticals Chief Scientific Officer to Receive National Kidney Foundation’s Market Innovation Award

Ulf Meier-Kriesche, MD, FAST, Chief Scientific Officer of Veloxis Pharmaceuticals, will receive the Market Innovation Award at the National Kidney Foundation’s 1st Annual North Carolina Honors Reception.

Read More
Press Release
PRESS RELEASE
2023-04-18

Veloxis Pharmaceuticals Partners with Donate Life NC on Gift of Life Gala

Veloxis Pharmaceuticals, a fully integrated specialty pharmaceutical company, is pleased to announce its support of Donate Life North Carolina as the premier sponsor of the 2023 Gift of Life Gala: heART of the Matter on Thursday, April 20th at the Prestonwood Country Club in Cary, N.C.

Read More